Related Experiment Videos
[Hallucinogenic mushrooms]
Dagmara Reingardiene1, Jolita Vilcinskaite, Robertas Lazauskas
1Clinic of Intensive Therapy, Kaunas University of Medicine,Kaunas, Lithuania.
Medicina (Kaunas, Lithuania)
|January 13, 2006
Summary
Hallucinogenic mushrooms contain psilocybin, a psychoactive compound. This review covers their history, effects, and treatment for toxicity.
Area of Science:
- Mycology
- Pharmacology
- Toxicology
Background:
- Hallucinogenic mushrooms, containing psilocybin, are psychoactive fungi.
- Their popularity as hallucinogens leads to significant toxicity concerns.
- Psilocybin and psilocin are structurally similar to LSD.
Purpose of the Study:
- To review the history and epidemiology of hallucinogenic mushroom use.
- To detail the pharmacology, pharmacodynamics, and pharmacokinetics of psilocybin.
- To outline clinical effects, symptoms, and treatment of psilocybin ingestion.
Main Methods:
- Literature review of scientific articles and case studies.
- Analysis of historical records and epidemiological data.
- Synthesis of pharmacological and clinical information.
Main Results:
- Hallucinogenic mushrooms rapidly affect the central nervous system within 0.5-1 hour.
- Ingestion can cause ataxia, hyperkinesis, and hallucinations.
- Psilocybin and psilocin are the primary psychoactive compounds.
Conclusions:
- Understanding psilocybin mushroom toxicity is crucial due to widespread use.
- Comprehensive knowledge of their effects and management is necessary.
- Further research into treatment and prognosis is warranted.